Chemoinformaics analysis of 4-O-METHYL-GLUCURONIC-ACID
| Molecular Weight | 208.166 | nRot | 2 |
| Heavy Atom Molecular Weight | 196.07 | nRig | 7 |
| Exact Molecular Weight | 208.058 | nRing | 1 |
| Solubility: LogS | -0.173 | nHRing | 1 |
| Solubility: LogP | -2.325 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 25.3055 |
| nHD | 4 | BPOL | 16.3785 |
| QED | 0.397 |
| Synth | 3.833 |
| Natural Product Likeliness | 2.046 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.176 |
| HIA | 0.915 |
| CACO-2 | -6.143 |
| MDCK | 0.000638327 |
| BBB | 0.646 |
| PPB | 0.117164 |
| VDSS | 0.283 |
| FU | 0.816024 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.052 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.207 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.127 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.004 |
| CL | 1.628 |
| T12 | 0.816 |
| hERG | 0.013 |
| Ames | 0.023 |
| ROA | 0.181 |
| SkinSen | 0.042 |
| Carcinogencity | 0.007 |
| EI | 0.015 |
| Respiratory | 0.037 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.901881 |